IMU: Big Dreams, Tough Lessons and Yep… Another Thread No One Asked For, page-5

Hi @iluminaughty, very good summary of the state of play.
Regarding your questions;
Yes I am still in the ride and have a hopeful belief that we can still bring new immunotherapy drugs to those exposed to cancer.
I think the main thing that keeps me holding is the belief in the people running the company, and yes I know this is very much a contrarian view.
Yuman Fong to me is a future Nobel prize recipient, Leslie is a very passionate advocate for cancer sufferers and many of the team are dedicated to this cause.
Hopper is a visionary even though I don’t believe he has respect or sympathy for those invested in his dreams.
I definitely don’t think these people are here just for the money, they do not strike me as being that way inclined.
We know that the trials they are conducting are all cutting edge, the oncarlytic trial particularly shows great promise if successful.
The IP alone must be worth hundreds of Millions if not , billions.
The last question is a tough one as you could pretty much say this for any speculative investment.
However knowing what I know now and having the opportunity to invest at today’s price, yes I would maybe not as much as I have because I can safely say I have gone in much deeper that I should have believing that we would have seen interest from BP much sooner.
But that is on me not the company.

DYOR opinion only